Source: MarketScreener

Voluntis: AptarGroup : Voluntis and Tilak Healthcare Partner to Help Cancer Patients Better Manage Ocular Toxicities

(marketscreener.com) Voluntis, an Aptar Pharma company and leader in digital therapeutics, today announced a partnership with Tilak Healthcare, a digital therapeutics company specializing in clinically validated medical mobile apps for chronic diseases. Under this new collaboration, both companies will combine Tilak's OdySight® Care mobile...https://www.marketscreener.com/quote/stock/APTARGROUP-INC-11708/news/AptarGroup-Voluntis-and-Tilak-Healthcare-Partner-to-Help-Cancer-Patients-Better-Manage-Ocular-Toxi-39555806/?utm_medium=RSS&utm_content=20220223

Read full article »
Est. Annual Revenue
$5.0-25M
Est. Employees
25-100
Pierre Leurent's photo - Co-Founder & CEO of Voluntis

Co-Founder & CEO

Pierre Leurent

CEO Approval Rating

83/100

Read more